Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
filingDate |
1970-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba1f69a0bcb54f8c395bb0fd0e54e0d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d04d09f4aba1c05d7e0a9dc9b6360589 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1796e6512a10da269d3b6fa9582c60b |
publicationDate |
1973-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CH-538283-A |
titleOfInvention |
New contraceptive means |
abstract |
Anticonceptional product comprises an orally active progestin (I) pref. lynestrenol) and an orally active progestagen (II) (pref. DELTA4,6-17alpha-acetoxy-3,20-dioxo-19-nor-pregnadiene), the quantity of each of (I) and (II) is the daily unit does being less than the daily dose of each component necessary to ensure sure contraception when they are used along in the "non-stop-luteal-supplementation" method. |
priorityDate |
1970-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |